BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao Y, Zhang Y, Chen Y, Li J, Zhang Z, Sun Y, Shen H, Zhao Z, Huang Z, Zhang W, Chen W, Shen Z. Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice. Hum Gene Ther 2019;30:286-301. [PMID: 30101604 DOI: 10.1089/hum.2018.059] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu B, Wang B, Zhang X, Lock R, Nash T, Vunjak-Novakovic G. Cell type-specific microRNA therapies for myocardial infarction. Sci Transl Med 2021;13:eabd0914. [PMID: 33568517 DOI: 10.1126/scitranslmed.abd0914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tu Y, Hu Y. MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities. Metab Brain Dis 2021;36:1341-51. [PMID: 33842985 DOI: 10.1007/s11011-021-00724-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Pontemezzo E, Foglio E, Vernucci E, Magenta A, D'Agostino M, Sileno S, Astanina E, Bussolino F, Pellegrini L, Germani A, Russo MA, Limana F. miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1. Int J Mol Sci 2021;22:4971. [PMID: 34067060 DOI: 10.3390/ijms22094971] [Reference Citation Analysis]
4 Zhao P, Zhou W, Zhang Y, Li J, Zhao Y, Pan L, Shen Z, Chen W, Hui J. Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice. J Cell Mol Med. 2020;24:2593-2609. [PMID: 31930778 DOI: 10.1111/jcmm.14972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
5 Siebert V, Allencherril J, Ye Y, Wehrens XHT, Birnbaum Y. The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury. Cardiovasc Drugs Ther 2019;33:489-98. [PMID: 31332654 DOI: 10.1007/s10557-019-06893-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
6 Rahimian N, Razavi ZS, Aslanbeigi F, Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR, Mirzaei H. Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol 2021;161:896-912. [PMID: 33781555 DOI: 10.1016/j.ygyno.2021.03.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Wang S, Li L, Liu T, Jiang W, Hu X. miR-19a/19b-loaded exosomes in combination with mesenchymal stem cell transplantation in a preclinical model of myocardial infarction. Regen Med 2020;15:1749-59. [PMID: 32772806 DOI: 10.2217/rme-2019-0136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
8 Li Y, Li Q, Zhang O, Guan X, Xue Y, Li S, Zhuang X, Zhou B, Miao G. miR-202-5p protects rat against myocardial ischemia reperfusion injury by downregulating the expression of Trpv2 to attenuate the Ca 2+ overload in cardiomyocytes. J Cell Biochem 2019;120:13680-93. [PMID: 31062423 DOI: 10.1002/jcb.28641] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
9 Shen H, Cui G, Li Y, Ye W, Sun Y, Zhang Z, Li J, Xu G, Zeng X, Zhang Y, Zhang W, Huang Z, Chen W, Shen Z. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem Cell Res Ther 2019;10:17. [PMID: 30635025 DOI: 10.1186/s13287-018-1111-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
10 Sileno S, Beji S, D'Agostino M, Carassiti A, Melillo G, Magenta A. microRNAs involved in psoriasis and cardiovascular diseases. Vasc Biol 2021;3:R49-68. [PMID: 34291190 DOI: 10.1530/VB-21-0007] [Reference Citation Analysis]
11 Peng Q, Li L, Bi X. Long Noncoding RNA Small Nuclear RNA Host Gene 7 Knockdown Protects Mouse Cardiac Fibroblasts Against Myocardial Infarction by Regulating miR-455-3p/Platelet-Activating Factor Receptor Axis. J Cardiovasc Pharmacol 2021;77:796-804. [PMID: 33929392 DOI: 10.1097/FJC.0000000000001012] [Reference Citation Analysis]
12 Huang K, Wen S, Huang J, Wang F, Pang L, Wang Y, Sun X. Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy. Biomed Res Int 2020;2020:8925420. [PMID: 33015184 DOI: 10.1155/2020/8925420] [Reference Citation Analysis]
13 Wang W, Zheng H. Myocardial Infarction: The Protective Role of MiRNAs in Myocardium Pathology. Front Cardiovasc Med 2021;8:631817. [PMID: 33748196 DOI: 10.3389/fcvm.2021.631817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hu PF, Ma CY, Sun FF, Chen WP, Wu LD. Follistatin-like protein 1 (FSTL1) promotes chondrocyte expression of matrix metalloproteinase and inflammatory factors via the NF-κB pathway. J Cell Mol Med 2019;23:2230-7. [PMID: 30644158 DOI: 10.1111/jcmm.14155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
15 Dong J, Zhu W, Wan D. Downregulation of microRNA-21-5p from macrophages-derived exosomes represses ventricular remodeling after myocardial infarction via inhibiting tissue inhibitors of metalloproteinase 3. Int Immunopharmacol 2021;96:107611. [PMID: 33882443 DOI: 10.1016/j.intimp.2021.107611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wang S, Liu Z. Inhibition of microRNA-143-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting FSTL1. Neuromolecular Med 2021. [PMID: 33709299 DOI: 10.1007/s12017-021-08650-6] [Reference Citation Analysis]
17 Zhang L, Zhao W, Bao D, Sun K, Li P, Gao Z, Lu Z. miR-9-5p promotes wear-particle-induced osteoclastogenesis through activation of the SIRT1/NF-κB pathway. 3 Biotech 2021;11:258. [PMID: 33987074 DOI: 10.1007/s13205-021-02814-8] [Reference Citation Analysis]
18 Sendur SN, Hazirolan T, Aydin B, Lay I, Alikasifoglu M, Erbas T. Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly. Acta Cardiol 2021;:1-10. [PMID: 34233581 DOI: 10.1080/00015385.2021.1948206] [Reference Citation Analysis]
19 Lian F, Cheng P, Ruan C, Ling X, Wang X, Pan M, Chen M, Shen A, Gao S. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Biomedicine & Pharmacotherapy 2019;117:109124. [DOI: 10.1016/j.biopha.2019.109124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wu Z, Cheng S, Wang S, Li W, Liu J. BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice. Int Immunopharmacol 2021;93:107389. [PMID: 33582480 DOI: 10.1016/j.intimp.2021.107389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zheng J, Peng B, Zhang Y, Ai F, Hu X. miR-9 knockdown inhibits hypoxia-induced cardiomyocyte apoptosis by targeting Yap1. Life Sci 2019;219:129-35. [PMID: 30639391 DOI: 10.1016/j.lfs.2019.01.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
22 Li X, Yang Y, Chen S, Zhou J, Li J, Cheng Y. Epigenetics-based therapeutics for myocardial fibrosis. Life Sci 2021;271:119186. [PMID: 33577852 DOI: 10.1016/j.lfs.2021.119186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Xiong W, Feng S, Wang H, Qing S, Yang Y, Zhao Y, Zeng Z, Gong J. Identification of candidate genes and pathways in limonin-mediated cardiac repair after myocardial infarction. Biomed Pharmacother 2021;142:112088. [PMID: 34470729 DOI: 10.1016/j.biopha.2021.112088] [Reference Citation Analysis]
24 Gao QY, Zhang HF, Chen ZT, Li YW, Wang SH, Wen ZZ, Xie Y, Mai JT, Wang JF, Chen YX. Construction and Analysis of a ceRNA Network in Cardiac Fibroblast During Fibrosis Based on in vivo and in vitro Data. Front Genet 2020;11:503256. [PMID: 33552116 DOI: 10.3389/fgene.2020.503256] [Reference Citation Analysis]
25 Qu Y, Zhang J, Zhang J, Xiao W. MiR-708-3p Alleviates Inflammation and Myocardial Injury After Myocardial Infarction by Suppressing ADAM17 Expression. Inflammation 2021;44:1083-95. [PMID: 33492555 DOI: 10.1007/s10753-020-01404-9] [Reference Citation Analysis]
26 Cai X, Li B, Wang Y, Zhu H, Zhang P, Jiang P, Yang X, Sun J, Hong L, Shao L. CircJARID2 Regulates Hypoxia-Induced Injury in H9c2 Cells by Affecting miR-9-5p-Mediated BNIP3. J Cardiovasc Pharmacol 2021;78:e77-85. [PMID: 34009856 DOI: 10.1097/FJC.0000000000001033] [Reference Citation Analysis]